Skip to main navigation Skip to search Skip to main content

Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis

Research output: Contribution to journal › Short survey › peer-review

Original languageEnglish (US)
Pages (from-to)932-934.e3
JournalGastroenterology
Volume160
Issue number3
DOIs
StatePublished - Feb 2021

Keywords

  • Cancer Outcome
  • Checkpoint Inhibitor Colitis
  • Immunotherapy
  • Refractory

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this